Sleep · Sleep peptide (research)
DSIP (aka Emideltide)
- Drug class
- Sleep peptide (research)
- Status
- Compounded (503A)
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What DSIP (aka Emideltide) is studied for
- Deep sleep support (research)
- Sleep architecture (research)
- Recovery (research)
Mechanism of action
DSIP (aka Emideltide) is being studied in the sleep category. Delta Sleep-Inducing Peptide (Emideltide) for deep sleep architecture. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is DSIP (aka Emideltide)?
DSIP (aka Emideltide) is a sleep peptide. Delta Sleep-Inducing Peptide (Emideltide) for deep sleep architecture.
What is DSIP (aka Emideltide) studied for?
Published research has examined DSIP (aka Emideltide) for deep sleep support, sleep architecture, recovery. Human clinical evidence varies by indication.
Is DSIP (aka Emideltide) FDA-approved?
No. DSIP (aka Emideltide) is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is DSIP (aka Emideltide) used in research?
Protocols vary by study. DSIP (aka Emideltide) is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for DSIP (aka Emideltide) is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
Build the DSIP (aka Emideltide) protocol stack
Research protocols commonly pair DSIP (aka Emideltide) with the peptides below. Add all three vials to unlock the bundle discount at checkout.
Related peptides in Sleep
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- Sleep & menopauseJournal
- Epitalon — circadian repairPeptide
- Sleep disruptionSymptom
